| 1501 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1502 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1503 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
75 |
| 1504 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
56 |
| 1505 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
23 |
| 1506 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
54 |
| 1507 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
69 |
| 1508 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1509 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1510 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1511 |
Bone Marrow Family |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
72 |
| 1512 |
Bone Marrow Family |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation |
Hematology |
2024 |
Standard Therapy |
Poland |
55 |
| 1513 |
Bone Marrow Family |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
63 |
| 1514 |
Bone Marrow Family |
Allogeneic |
Follicular Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
48 |
| 1515 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
65 |
| 1516 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Germany |
58 |
| 1517 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
70 |
| 1518 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome – Refractory Cytopenia Of Childhood |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1519 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome/ Myeloproliferative Neoplasms |
Hematology |
2024 |
Standard Therapy |
Germany |
61 |
| 1520 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome-MPN |
Hematology |
2024 |
Standard Therapy |
Poland |
71 |
| 1521 |
Bone Marrow Family |
Allogeneic |
Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1522 |
Bone Marrow Family |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
64 |
| 1523 |
Bone Marrow Family |
Allogeneic |
Polycythemia Vera/Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Poland |
74 |
| 1524 |
Bone Marrow Family |
Allogeneic |
Primary Myelofibrosis |
Hematology |
2024 |
Standard Therapy |
Germany |
62 |
| 1525 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
68 |
| 1526 |
Bone Marrow Family |
Allogeneic |
Myelodysplasia |
Hematology |
2024 |
Standard Therapy |
United Kingdom |
57 |
| 1527 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Germany |
69 |
| 1528 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
58 |
| 1529 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
60 |
| 1530 |
Bone Marrow Family |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
71 |
| 1531 |
Bone Marrow Family |
Allogeneic |
High risk Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Germany |
69 |
| 1532 |
Bone Marrow Family |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
USA |
74 |
| 1533 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
15 |
| 1534 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
8 |
| 1535 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1536 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
8 |
| 1537 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
52 |
| 1538 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
57 |
| 1539 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
66 |
| 1540 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
5 |
| 1541 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
54 |
| 1542 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
56 |
| 1543 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
3 |
| 1544 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1545 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1546 |
Bone Marrow |
Allogeneic |
Adrenoleukodystrophy |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1547 |
Bone Marrow |
Allogeneic |
B-Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1548 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
4 |
| 1549 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
41 |
| 1550 |
Bone Marrow |
Allogeneic |
Chronic Lymphocytic Leukemia Richter Transformation |
Hematology |
2024 |
Standard Therapy |
Poland |
55 |
| 1551 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
67 |
| 1552 |
Bone Marrow |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1553 |
Bone Marrow |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
61 |
| 1554 |
Bone Marrow |
Allogeneic |
Genetically Determined Thrombocytopenia |
Hematology |
2024 |
Standard Therapy |
Poland |
4 |
| 1555 |
Bone Marrow |
Allogeneic |
High Risk Acute Myeloid Leukaemia |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1556 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
32 |
| 1557 |
Bone Marrow |
Allogeneic |
Inherited Metabolic Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
11 |
| 1558 |
Bone Marrow |
Allogeneic |
Mds-Rcc Relapse |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1559 |
Bone Marrow |
Allogeneic |
Mixed Cellularity Hodgkin Lymphoma |
Hematology |
2024 |
Standard Therapy |
Poland |
43 |
| 1560 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1561 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
8 |
| 1562 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1563 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
67 |
| 1564 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1565 |
Bone Marrow |
Allogeneic |
Osteopetrosis type B |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1566 |
Bone Marrow |
Allogeneic |
Other Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1567 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1568 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency Xlp-1 |
Hematology |
2024 |
Standard Therapy |
Poland |
18 |
| 1569 |
Bone Marrow |
Allogeneic |
Relapse T-Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1570 |
Bone Marrow |
Allogeneic |
Secondary Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
4 |
| 1571 |
Bone Marrow |
Allogeneic |
Secondary Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
15 |
| 1572 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1573 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
3 |
| 1574 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
10 |
| 1575 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
21 |
| 1576 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
18 |
| 1577 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
49 |
| 1578 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
16 |
| 1579 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
24 |
| 1580 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
13 |
| 1581 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
14 |
| 1582 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
21 |
| 1583 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Poland |
7 |
| 1584 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2024 |
Standard Therapy |
Poland |
2 |
| 1585 |
Bone Marrow |
Allogeneic |
Severe Congenital Neutropenia |
Hematology |
2024 |
Standard Therapy |
Poland |
1 |
| 1586 |
Bone Marrow |
Allogeneic |
Shwachman-Diamond Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
10 |
| 1587 |
Bone Marrow |
Allogeneic |
Sickle Cell Disease |
Hematology |
2024 |
Standard Therapy |
Poland |
9 |
| 1588 |
Bone Marrow |
Allogeneic |
Biphenotypic Acute Leukemia |
Hematology |
2024 |
Standard Therapy |
Ukraine |
10 |
| 1589 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Poland |
58 |
| 1590 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
United Kingdom |
12 |
| 1591 |
Bone Marrow |
Allogeneic |
hemophagocytic lymphohistiocytosis |
Hematology |
2024 |
Standard Therapy |
Sweden |
4 months |
| 1592 |
Bone Marrow |
Allogeneic |
Severe combined immunodeficiency |
Hematology |
2024 |
Standard Therapy |
Germany |
1 |
| 1593 |
Bone Marrow |
Allogeneic |
Beta-Thalassemia Major |
Hematology |
2024 |
Standard Therapy |
India |
11 |
| 1594 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Austria |
4 |
| 1595 |
Bone Marrow |
Allogeneic |
Acute Myelogenous Leukemia |
Hematology |
2024 |
Standard Therapy |
Norway |
33 |
| 1596 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Spain |
16 |
| 1597 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2024 |
Standard Therapy |
Switzerland |
5 |
| 1598 |
Bone Marrow |
Allogeneic |
T- Acute Lymphoblastic Leukemia |
Hematology |
2024 |
Standard Therapy |
Ireland |
6 |
| 1599 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2024 |
Standard Therapy |
Poland |
12 |
| 1600 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2024 |
Standard Therapy |
USA |
4 months |